Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevan

Showing results (841-850 of 1,857) with videos related to

Pageof 186
Sort By:
Science (New York, N.Y.)|September 25, 2025
Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunityDouglas R Wassarman, Patrick Pfaff, Joao A Paulo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 27, 2009
Physical inactivity and chronic kidney disease in Australian adults: the AusDiab studySarah L White, David W Dunstan, Kevan R Polkinghorne, et al.
Frontiers in Endocrinology|November 24, 2025
Immune checkpoint inhibitor-induced diabetes can potentially be effectively treated with infliximab: a case report of two patientsNoam Savion Gaiger, Michael E Hurwitz, Navid Hafez, et al.
FEBS Letters|July 11, 2015
A synthetic tRNA for EF-Tu mediated selenocysteine incorporation in vivo and in vitroCorwin Miller, Markus J Bröcker, Laure Prat, et al.
Journal of Clinical Imaging Science|July 23, 2015
Magnetic Resonance Imaging of Non-ischemic Cardiomyopathies: A Pictorial EssayCristina I Olivas-Chacon, Carola Mullins, Kevan Stewart, et al.
Diabetes|November 30, 2006
Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetesNicole A Sherry, Jake A Kushner, Mariela Glandt, et al.
Epilepsia|June 4, 2011
Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteersJonathan Bullman, Andrew Nicholls, Kevan Van Landingham, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 11, 2022
Progression to Anti-TNF Treatment in Very Early Onset Inflammatory Bowel Disease PatientsAdi Eindor-Abarbanel, Laura Meleady, Sally Lawrence, et al.
Innate Immunity|April 29, 2010
Review: Structural determinants of pattern recognition by lung collectinsBarbara A Seaton, Erika C Crouch, Francis X McCormack, et al.
Plos Biology|February 13, 2009
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2Morris E Feldman, Beth Apsel, Aino Uotila, et al.
Pageof 186

Showing results (841-850 of 1,857) with videos related to

Sort By:
Pageof 186
Science (New York, N.Y.)|September 25, 2025
Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunityDouglas R Wassarman, Patrick Pfaff, Joao A Paulo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 27, 2009
Physical inactivity and chronic kidney disease in Australian adults: the AusDiab studySarah L White, David W Dunstan, Kevan R Polkinghorne, et al.
Frontiers in Endocrinology|November 24, 2025
Immune checkpoint inhibitor-induced diabetes can potentially be effectively treated with infliximab: a case report of two patientsNoam Savion Gaiger, Michael E Hurwitz, Navid Hafez, et al.
FEBS Letters|July 11, 2015
A synthetic tRNA for EF-Tu mediated selenocysteine incorporation in vivo and in vitroCorwin Miller, Markus J Bröcker, Laure Prat, et al.
Journal of Clinical Imaging Science|July 23, 2015
Magnetic Resonance Imaging of Non-ischemic Cardiomyopathies: A Pictorial EssayCristina I Olivas-Chacon, Carola Mullins, Kevan Stewart, et al.
Diabetes|November 30, 2006
Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetesNicole A Sherry, Jake A Kushner, Mariela Glandt, et al.
Epilepsia|June 4, 2011
Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteersJonathan Bullman, Andrew Nicholls, Kevan Van Landingham, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 11, 2022
Progression to Anti-TNF Treatment in Very Early Onset Inflammatory Bowel Disease PatientsAdi Eindor-Abarbanel, Laura Meleady, Sally Lawrence, et al.
Innate Immunity|April 29, 2010
Review: Structural determinants of pattern recognition by lung collectinsBarbara A Seaton, Erika C Crouch, Francis X McCormack, et al.
Plos Biology|February 13, 2009
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2Morris E Feldman, Beth Apsel, Aino Uotila, et al.
Pageof 186